Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.30 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19117372 | 0.87 | — | — | |
| SCHEMBL29693305 | 0.87 | TSHR (0.50) | TSHRLMNATHRBALDH1A1SLC22A1 | |
| SCHEMBL1032024 | 0.79 | — | — | |
| SCHEMBL19402629 | 0.77 | — | — | |
| SCHEMBL20105091 | 0.76 | — | — | |
| Hexane SCHEMBL28529694 | 0.72 | TSHR (0.58) | TSHRLMNATHRBALDH1A1SLC22A1 | |
| SCHEMBL10899969 | 0.69 | ANPEP (0.53) | ANPEPTSHRLMNATHRBPCSK9 | |
| Heptane SCHEMBL20637816 | 0.69 | TSHR (0.67) | TSHRLMNATHRBALDH1A1SLC22A1 | |
| SCHEMBL1237 | 0.69 | ANPEP (0.53) | ANPEPTSHRLMNATHRBPCSK9 | |
| SCHEMBL19439490 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| EP-4385972-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | Idemitsu Kosan Co.,Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023017779-A1 | METHOD FOR PRODUCING α-OLEFIN OLIGOMER COMPOSITION | 出光興産株式会社 | 2023-02-16 | — | — | WO | disclosed |
| EP-1477499-B1 | PROCESS FOR PRODUCING HIGH-FLuidity 1-BUTENE-based POLYMER | IDEMITSU KOSAN CO (JP) | 2015-01-14 | — | — | EP | disclosed |
| EP-2113521-B1 | ALPHA-OLEFIN POLYMER AND PROCESS FOR PRODUCTION THEREOF | IDEMITSU KOSAN CO (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-8178635-B2 | α-Olefin polymer and process for production thereof | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-7968665-B2 | Hot melt adhesives; polymerization catalysts | IDEMITSU KOSAN CO., LTD. (JP) | 2011-06-28 | — | — | US | disclosed |
| EP-1229020-B1 | TRANSITION METAL COMPOUND, OLEFIN POLYMERIZATION CATALYST, AND METHOD OF POLYMERIZING OLEFIN | IDEMITSU KOSAN CO (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100036066-A1 | ALPHA-OLEFIN POLYMER AND PROCESS FOR PRODUCTION THEREOF | IDEMITSU KOSAN CO., LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2113521-A1 | -OLEFIN POLYMER AND PROCESS FOR PRODUCTION THEREOF | Idemitsu Kosan Co., Ltd. (JP) | 2009-11-04 | — | — | EP | disclosed |
| EP-0389084-B1 | Process for producing a polyborosilazane | TONEN CORP (JP) | 1995-09-20 | — | — | EP | disclosed |
| EP-0667359-A1 | OLEFIN COPOLYMERS AND PROCESS FOR PRODUCING THE SAME | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1995-08-16 | — | — | EP | disclosed |
| EP-0591756-A2 | Polymerization catalysts and process for producing polymers | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-04-13 | — | — | EP | disclosed |
| EP-0590486-A2 | Polymerization catalysts and process for producing polymers | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-04-06 | — | — | EP | disclosed |
| US-5292830-A | Silane, silazane, boron block crosslinked copolymers | TONEN CORPORATION (JP) | 1994-03-08 | — | — | US | disclosed |
| EP-0519496-A1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | Tonen Corporation (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5128286-A | BORON-CONTAINING, SILICON NITRIDE-BASED CERAMIC SHAPED BODY | TONEN CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| US-5030744-A | Polyborosilazane and process for producing same | TONEN CORPORATION (JP) | 1991-07-09 | — | — | US | disclosed |
| EP-0404503-A1 | Boron-containing, silicon nitride-based ceramic shaped body production process | Tonen Corporation (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240308936-A1 | METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION | OXER1, AMY1A, MACF1 | ANPEP 4578/4885TSHR 4330/4885LMNA 3220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.